| Comparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis T Li, K Lindsley, B Rouse, H Hong, Q Shi, DS Friedman, R Wormald, ... Ophthalmology 123 (1), 129-140, 2016 | 310 | 2016 |
| Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis of randomized … RD Lopes, H Hong, RE Harskamp, DL Bhatt, R Mehran, CP Cannon, ... JAMA cardiology 4 (8), 747-755, 2019 | 236 | 2019 |
| Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis E Mayo-Wilson, N Fusco, T Li, H Hong, JK Canner, K Dickersin Journal of clinical epidemiology 86, 39-50, 2017 | 126 | 2017 |
| A Bayesian missing data framework for generalized multiple outcome mixed treatment comparisons H Hong, H Chu, J Zhang, BP Carlin Research synthesis methods 7 (1), 6-22, 2016 | 118 | 2016 |
| Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy E Mayo-Wilson, T Li, N Fusco, L Bertizzolo, JK Canner, T Cowley, P Doshi, ... Journal of clinical epidemiology 91, 95-110, 2017 | 114 | 2017 |
| Optimal antithrombotic regimens for patients with atrial fibrillation undergoing percutaneous coronary intervention: an updated network meta-analysis RD Lopes, H Hong, RE Harskamp, DL Bhatt, R Mehran, CP Cannon, ... JAMA cardiology 5 (5), 582-589, 2020 | 101 | 2020 |
| Comparing Bayesian and frequentist approaches for multiple outcome mixed treatment comparisons H Hong, BP Carlin, TA Shamliyan, JF Wyman, R Ramakrishnan, ... Medical Decision Making 33 (5), 702-714, 2013 | 97 | 2013 |
| Comparison of systemic treatments for metastatic castration-sensitive prostate cancer: a systematic review and network meta-analysis. L Wang, CJ Paller, H Hong, A De Felice, GC Alexander, O Brawley JAMA Oncol 7 (3), 412-420, 2021 | 86 | 2021 |
| Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting CW Wester, JR Koethe, BE Shepherd, SE Stinnette, PF Rebeiro, AM Kipp, ... AIDS (London, England) 25 (12), 1471, 2011 | 74 | 2011 |
| Longitudinal changes in nursing home resident–reported quality of life: The role of facility characteristics TP Shippee, H Hong, C Henning-Smith, RL Kane Research on Aging 37 (6), 555-580, 2015 | 57 | 2015 |
| Guidance on the implementation and reporting of a drug safety Bayesian network meta‐analysis D Ohlssen, KL Price, H Amy Xia, H Hong, J Kerman, H Fu, G Quartey, ... Pharmaceutical Statistics 13 (1), 55-70, 2014 | 44 | 2014 |
| Harms are assessed inconsistently and reported inadequately part 1: systematic adverse events E Mayo-Wilson, N Fusco, T Li, H Hong, JK Canner, K Dickersin, ... Journal of clinical epidemiology 113, 20-27, 2019 | 43 | 2019 |
| Bayesian hierarchical models for network meta-analysis incorporating nonignorable missingness J Zhang, H Chu, H Hong, BA Virnig, BP Carlin Statistical methods in medical research 26 (5), 2227-2243, 2017 | 42 | 2017 |
| Rejoinder to the discussion of “a Bayesian missing data framework for generalized multiple outcome mixed treatment comparisons,” by S. Dias and AE Ades H Hong, H Chu, J Zhang, BP Carlin Research synthesis methods 7 (1), 29, 2016 | 42 | 2016 |
| Keloid excision and adjuvant treatments: a network meta-analysis C Siotos, AC Uzosike, H Hong, SM Seal, GD Rosson, CM Cooney, ... Annals of plastic surgery 83 (2), 154-162, 2019 | 39 | 2019 |
| Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse events E Mayo-Wilson, N Fusco, T Li, H Hong, JK Canner, K Dickersin, ... Journal of clinical epidemiology 113, 11-19, 2019 | 38 | 2019 |
| Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events E Mayo-Wilson, N Fusco, H Hong, T Li, JK Canner, K Dickersin Trials 20 (1), 1-11, 2019 | 30 | 2019 |
| Incorporation of individual‐patient data in network meta‐analysis for multiple continuous endpoints, with application to diabetes treatment H Hong, H Fu, KL Price, BP Carlin Statistics in Medicine 34 (20), 2794-2819, 2015 | 30 | 2015 |
| Case study comparing bayesian and frequentist approaches for multiple treatment comparisons BP Carlin, H Hong, TA Shamliyan, F Sainfort, RL Kane Agency for Healthcare Research and Quality (US), 2013 | 27 | 2013 |
| Meta-analysis of rare adverse events in randomized clinical trials: Bayesian and frequentist methods H Hong, C Wang, GL Rosner Clinical Trials 18 (1), 3-16, 2021 | 20 | 2021 |
